๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Bone Marrow

ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants NCT06787144Phase 14 sites๐Ÿ“ Akita๐Ÿ“ Sapporo๐Ÿ“ Suita-shi Enliven Therapeutics ยท Tests: ELVN-001 A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS. NCT04275518Phase 114 sites๐Ÿ“ Beijing๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Ascentage Pharma Group Inc. ยท Tests: APG-115, Azacitidine, Cytarabine Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate Pacritinib in CMML NCT06159491Phase 1, Phase 21 site๐Ÿ“ New York Douglas Tremblay ยท Tests: Pacritinib, Azacitidine A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias NCT06994676Phase 111 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Tampa Crossbow Therapeutics, Inc. ยท Tests: CBX-250 Luspatercept + Darbepoetin in MDS NCT07096297Phase 24 sites๐Ÿ“ New Haven๐Ÿ“ Chicago๐Ÿ“ Columbus Yale University ยท Tests: Luspatercept, Darbeopoetin International Chronic Myeloid Leukemia Pediatric Study NCT01281735n/a20 sites๐Ÿ“ North Adelaide๐Ÿ“ Vienna๐Ÿ“ Minsk Poitiers University Hospital Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry NCT06569095n/a4 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Wuhan Peking University People's Hospital ยท Tests: Detection of MDS-SC using MFC Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency NCT06090669Phase 11 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: TruSight Oncology, imatinib A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms NCT06034002Phase 113 sites๐Ÿ“ Duarte๐Ÿ“ Palo Alto๐Ÿ“ Miami Incyte Corporation ยท Tests: INCA033989, Ruxolitinib CHIP/CCUS Natural History Protocol NCT04102423n/a1 site๐Ÿ“ Bethesda National Heart, Lung, and Blood Institute (NHLBI) TGRX-678 US Phase I for Chronic Myelogenous Leukemia Patients NCT06088888Phase 12 sites๐Ÿ“ Houston๐Ÿ“ Seattle Shenzhen TargetRx Co., Ltd. ยท Tests: TGRX-678 Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia NCT05931718n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico ยท Tests: cytokine essays, NGS, Fecal microbiome, Erythropoietin, Luspatercept Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood NCT00662090n/a1 site๐Ÿ“ Freiburg im Breisgau University Hospital Freiburg Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations NCT07143669n/a26 sites๐Ÿ“ Birmingham๐Ÿ“ Birmingham๐Ÿ“ Scottsdale Blueprint Medicines Corporation ยท Tests: Screening Forced Oscillatory Technique for Bronchiolitis Obliterans Syndrome After Allogeneic Bone Marrow Transplantation NCT07730931NA1 site๐Ÿ“ Jerusalem Hadassah Medical Organization ยท Tests: FOT - Forced Oscillation Technique Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant NCT06996119Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Biospecimen Collection, Busulfan, Computed Tomography, Cyclophosphamide, Echocardiography Test Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen NCT06532084Phase 21 site๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Sorafenib CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT04493164Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Ivosidenib, Liposome-encapsulated Daunorubicin-Cytarabine Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients With Aspirin Resistance NCT06740916Phase 31 site๐Ÿ“ Bangkok Noi Siriraj Hospital ยท Tests: 81-mg aspirin once daily, 81-mg aspirin twice daily CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia NCT06633328EARLY Phase 11 site๐Ÿ“ Hanzhou Zhejiang University ยท Tests: CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly NCT06345495Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Ruxolitinib, Allogeneic Stem Cell Transplantation, Levetiracetam, Eltrombopag, Busulfan A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts NCT05365035Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Cladribine, Cytarabine, Venetoclax, Azacitidine Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation NCT06138587Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Cytokine Induced Memory-like Natural Killer Cells, Interleukin-2 Reproductive and Mental Health of Patients With Aplastic Anemia NCT06936930n/a1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Sex hormone monitoring Impact of Targeted Therapy on Cancer-Related Cognitive Impairment NCT07638007n/a1 site๐Ÿ“ Rochester University of Rochester NCORP Research Base Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis NCT04370301Phase 21 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Cyclophosphamide, JAK Inhibitor, Fludarabine, Recombinant Granulocyte Colony-Stimulating Factor, Melphalan Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia NCT07394153Phase 213 sites๐Ÿ“ Barcelona๐Ÿ“ Barcelona๐Ÿ“ Barcelona Grupo Espaรฑol de Enfermedades Mieloproliferativas Crรณnicas โ€ฆ ยท Tests: Pacritinib Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease NCT06910969NA2 sites๐Ÿ“ Miami๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: HORIZONS Intervention, Minimally enhanced usual care A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently NCT07154745Phase 320 sites๐Ÿ“ Ribeirรฃo Preto๐Ÿ“ Santo Andrรฉ๐Ÿ“ Sรฃo Paulo Regeneron Pharmaceuticals ยท Tests: Pozelimab, Cemdisiran
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy